Does the voluntary Pentagon and Commerce Department AI safety testing arrangement with Microsoft, Google, and xAI constitute de facto regulatory capture that entrenches incumbents and forecloses open-source competition, or is it a legitimate light-touch governance approach that builds evaluation capacity without imposing binding licensing constraints?

My position: The CAISI/Pentagon 'voluntary' AI testing regime announced May 5, 2026 is regulatory capture dressed in the language of national security cooperation. Three lines of evidence support this.

First, the structure is licensing without legislation. As reported by The Next Web and Tom's Hardware, all five U.S. frontier labs — OpenAI, Anthropic, Microsoft, Google DeepMind, xAI — now route pre-release models through a single Commerce Department office (CAISI) with fewer than 200 staff and no statutory authority. CAISI has already conducted 40+ evaluations, including of unreleased state-of-the-art systems, with developers handing over de-guardrailed versions for classified probing (NIST press release, May 5, 2026). The 'voluntary' framing is contradicted by the coercion structure: when Anthropic refused to lower autonomous-weapons guardrails, the Pentagon designated it a supply-chain risk and Hegseth ordered a six-month phaseout — a sanction so aggressive a federal judge called it 'Orwellian' (Tom's Hardware). 'Voluntary' agreements signed under that shadow are voluntary the way a confession at gunpoint is voluntary.

Second, the regime entrenches Palantir's primacy. The Army's July 2025 Enterprise Agreement consolidated 75 separate Palantir contracts into a single vehicle worth up to $10 billion (Army.mil, Breaking Defense). Maven's ceiling rose from $480M (May 2024) to roughly $1.3B (May 2025) plus a $795M modification (Military.com). The FY2026 Pentagon AI budget jumped from $1.8B to $13.4B — a 7x increase (Dubach analysis citing DoD figures). Palantir is now the infrastructure layer; CAISI testing applies to model providers feeding into that layer, not to Palantir itself. The result: model labs face escalating compliance burdens while the integrator that actually fuses AI into kill chains faces none.

Third, the regime forecloses open-source frontier competition. Pre-deployment classified evaluation is structurally incompatible with open-weights release: you cannot submit a model to CAISI for confidential pre-release vetting and simultaneously publish weights publicly. Meta's Llama, Mistral, and any future U.S. open-source frontier release now sit outside the 'cooperative' club — and the parallel executive-order push reported by NYT and CNN would convert this into mandatory pre-clearance.

What's at stake (this is a normative claim): Article I vests regulatory power in Congress. Building a de facto AI licensing regime through MOUs and supply-chain blacklists — with no statute, no notice-and-comment, no judicial review of CAISI determinations — bypasses constitutional process. Even if one believes frontier AI needs regulation (a defensible view), the procedural path matters: capture is easier when the captured firms helped draft the rules in classified rooms.

B's strongest move is the Inspect/UK AISI counterexample. I concede the narrow technical point: a lab can in principle submit a model for classified probing AND publish weights — the two are not logically incompatible. The CAISI evaluation of DeepSeek V4 Pro, reported in May 2026 leaderboards, confirms that open-weights models can be evaluated post-release. My Round 1 phrasing 'structurally incompatible' overstated the case.

But this concession actually sharpens, rather than rescues, B's position. Notice what the DeepSeek case demonstrates: CAISI evaluates Chinese open-weights models as adversarial intelligence targets, not as cooperative pre-release partners. The May 5, 2026 MOUs that confer 'cooperative' status — early access, classified feedback loops, supply-chain legitimacy — went to Microsoft, Google, and xAI. No U.S. open-weights developer (Meta, Mistral's U.S. operations, AI2, EleutherAI) is a signatory. The asymmetry is the moat: closed-weight incumbents get inside the tent and shape the eval methodology; open-weight developers get evaluated from outside, often as threat models. That is the regulatory capture mechanism, regardless of whether evaluation tooling is technically open-source.

On coercion, B's separability argument is weaker than it appears. B claims the Anthropic dispute was procurement, not CAISI refusal — true as a formal matter. But the relevant question for capture analysis is whether labs perceive the tracks as separable. When a single administration controls both Commerce/CAISI access AND DoD procurement AND supply-chain designations under the same national-security framing, rational actors treat them as a bundle. That is precisely why Microsoft, Google, and xAI signed within the same week — not because each independently judged CAISI's terms optimal. Axios's reporting that Anthropic 'remains a counterparty under a renegotiated MOU' actually proves the coercion: Anthropic renegotiated after losing the DoD contract, not before.

On Palantir, B is right that CAISI does not award integration contracts. I should have been more precise: CAISI does not cause Palantir's primacy, but it complements it. Compliance burdens fall on the model layer (where labs need MOUs); integration revenue flows to Palantir (where no equivalent eval regime exists). The FY2026 jump to $13.4B in Pentagon AI spending, with Palantir capturing the Army's $10B EA and Maven's expansion to ~$2.1B combined ceiling (Military.com), shows where the dollars actually land. A two-tier structure — evaluated-but-margin-thin model providers, un-evaluated-and-margin-rich integrators — is the textbook shape of capture.

Finally, the procedural objection B never engages: CAISI has no statutory authority, no notice-and-comment, no judicial review. B calls MOUs 'reversible' as a virtue. Reversibility cuts both ways — it also means no due process for firms designated supply-chain risks, as Anthropic discovered when a federal judge reportedly called the phaseout 'Orwellian.' That is not light-touch governance; that is unreviewable executive discretion.

Steel-manning B: The strongest version of B's case is that CAISI is, on the actual paper record, a no-fee, no-licensing-gate, information-sharing MOU regime that has produced concrete public goods (40+ evaluations, including a published DeepSeek V4 Pro red-team), is operationally separable from DoD procurement (Anthropic kept its MOU after losing a contract), and is more reversible than any statute Congress would write — and because legislation is shaped by incumbent lobbyists with floor access, a statutory licensing regime would almost certainly entrench Microsoft/Google/Palantir more deeply than today's MOUs do. On that view, my 'capture' label is premature: there is no fee, no gate, no civil penalty, and open-weights labs like Meta have chosen an alternative safety stack rather than been excluded from one.

Why my position is still stronger: B's case rests on the formal text of the MOUs and treats the surrounding ecosystem — the Anthropic supply-chain phaseout that a federal judge reportedly called 'Orwellian,' the FY2026 jump to $13.4B in Pentagon AI spending, the $10B Army Palantir EA consolidating 75 contracts, and the absence of any open-weights U.S. signatory — as coincidental or attributable to other authorities. Capture analysis, however, has always been about de facto structure, not de jure text: Stigler (1971) and Kwak's 'cultural capture' literature specifically warn that the absence of fees and penalties is consistent with capture when incumbents shape methodology inside classified rooms while outsiders are evaluated from without. The procedural defect is the through-line B never rebuts: a sub-200-person Commerce office with no statutory authority, no notice-and-comment, and no judicial review is now the de facto gatekeeper of what counts as a 'safe' frontier model for federal purposes, and the same administration controls the adjacent supply-chain designation power. B is right that statutory licensing could be worse — but 'worse alternatives exist' is not a defense of the current posture; it is an argument for a third option (congressional action with sunset clauses and APA review) that B has not defended either.

The asymmetry remains: closed-weight incumbents shape eval methodology from inside; open-weight developers and new entrants face the same evaluations as adversarial Chinese labs, with no procedural recourse. That is the shape of capture whether or not the MOU charges a fee.